Drug prices
Finally! Humira’s biosimilars also hit the us market!
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
Andre Wencker
September 21, 2023
Care2Care International supports the Brussels Principles on the Sales of Medicines over the Internet, an initiative of the New-York based, non-profit organization, the Prescription Justice Institute.
This initiative 100% aligns with the values we share about affordable access to quality medications for all, an essential component of the right to health inscribed in article 25 of the Universal Declaration of Human Rights which was adopted by the United Nations in 1948 in Paris.
The USA was one of the original 48 signatory countries.
Eleanor ROOSEVELT reading the Universal Declaration of Human Rights
• The World Health Organization estimates that over two billion people lack regular access to essential medical products (i.e. medicines, vaccines, and diagnostics), which is exacerbated by a lack of affordability and local availability.
• The Internet has served as a disruptive force to traditional industry in the practice of pharmacy and trade in pharmaceutical products, allowing for the international sale of medical products to patients with a prescription.
• Failure to regulate the sale of medical products over the internet, including failure to differentiate between legitimate online pharmacies and rogue websites, poses a major public health risk.
• Governments are neglecting their human rights obligations when their populations do not have adequate access to affordable healthcare, including access to medical products.
Access to affordable medical products is a fundamental component of the right to health.
Patients with a prescription should be able to use the Internet to order safe, quality and affordable medical products for personal use.
National and regional legislation, regulation, and enforcement policies and actions should not prevent and/or deter patients with a prescription from importing safe, quality and affordable medical products for personal use.
Governments, international organizations and non-governmental organizations should promote a competitive online marketplace for safe and quality medical products in order to protect and facilitate affordability and access for all populations.
Policies that affect online access to medical products should aim to be evidence-based and patient-centered, including consideration of the fact that affordability and local availability can be significant barriers to access.
National, regional and international regulatory efforts should promote guidelines and best practices to ensure that online pharmacies are a reliable and safe source of medical products for patients. They should also identify and, through enforcement actions, sanction those online marketplaces engaging in the intentional sale and distribution of falsified and substandard medical products, as defined by the World Health Organization, as well as the sale of medical products to patients without a prescription.
Internet intermediaries, such as domain name registries, advertising networks, payment processors, financial institutions as well as physical and electronic mail and delivery services should not misuse their commercial power to disrupt online access to safe, quality and affordable medical products.
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
After wrapping up the 2023 enrollment, employers are now planning their next moves to mitigate the continuously growing healthcare costs impacting their plans. This is particularly true for pharmacy costs.
PhRMA, a Big Pharma lobbying group, released an advertising touting that drug prices were not fueling inflation. To prove it, they produce the graphic below.
Care2Care secured a strategic partnership with an innovative, transparent, 100% pass-through PBM.
Adding to our expertise in international drug sourcing, we expand our offer to the full pharmacy benefit management.
